Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from…

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic…

Viridian: Positive Chronic TED Data Likely To Lead To BLA Filing In 2H 2025 (VRDN)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…